E-LIB Suche - Ergebnisse für: Demel, Uta

1

Actionable loss of SLF2 drives B‐cell lymphomagenesis and i..:

Zhang, Le ; Wirth, Matthias ; Patra, Upayan...
EMBO Molecular Medicine. 15 (2023) 9 - p. , 2023

Link: https://doi.org/10.15252..

2

P1122: A PROSPECTIVE, NON-INTERVENTIONAL STUDY OF REAL-WORL..:

Habringer, Stefan ; Demel, Uta ; Fietz, Anne-Katrin...
HemaSphere. 7 (2023) S3 - p. e23520df , 2023

Link: https://doi.org/10.1097/..

3

A prospective observational study of real-world treatment a..:

Habringer, Stefan ; Demel, Uta M. ; Fietz, Anne-Katrin...
European Journal of Cancer. 196 (2024) - p. 113436 , 2024

Link: https://doi.org/10.1016/..

4

SUMOylation inhibition overcomes proteasome inhibitor resis..:

Heynen, Guus J. J. E. ; Baumgartner, Francis ; Heider, Michael...
Blood Advances. 7 (2023) 4 - p. 469-481 , 2023

Link: https://doi.org/10.1182/..

5

A complex proinflammatory cascade mediates the activation o..:

Demel, Uta Margareta ; Lutz, Raphael ; Sujer, Stefanie...
Blood Advances. 6 (2022) 11 - p. 3513-3528 , 2022

Link: https://doi.org/10.1182/..

6

Small-molecule SUMO inhibition for biomarker-informed B-cel..:

Demel, Uta M. ; Wirth, Matthias ; Yousefian, Schayan...
Haematologica. 108 (2022) 2 - p. 555-567 , 2022

Link: https://doi.org/10.3324/..

7

Activated SUMOylation restricts MHC class I antigen present..:

Demel, Uta M. ; Böger, Marlitt ; Yousefian, Schayan...
Journal of Clinical Investigation. 132 (2022) 9 - p. , 2022

Link: https://doi.org/10.1172/..

8

Hyperinflammation in patients with chronic granulomatous di..:

Weisser, Maren ; Demel, Uta M. ; Stein, Stefan...
Journal of Allergy and Clinical Immunology. 138 (2016) 1 - p. 219-228.e9 , 2016

Link: https://doi.org/10.1016/..

9

Actionable loss of SLF2 drives B‐cell lymphomagenesis and i..:

Zhang, Le ; Wirth, Matthias ; Patra, Upayan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493575/. , 2023

Link: http://www.ncbi.nlm.nih...

10

P1122: A PROSPECTIVE, NON-INTERVENTIONAL STUDY OF REAL-WORL..:

Habringer, Stefan ; Demel, Uta ; Fietz, Anne-Katrin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431142/. , 2023

Link: http://www.ncbi.nlm.nih...

11

Activated SUMOylation restricts MHC class I antigen present..:

Demel, Uta M ; Böger, Marlitt ; Yousefian, Schayan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057585/. , 2022

Link: http://www.ncbi.nlm.nih...

12

SUMOylation inhibition overcomes proteasome inhibitor resis..:

Heynen, Guus J. J. E ; Baumgartner, Francis ; Heider, Michael...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979771/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Small-molecule SUMO inhibition for biomarker-informed B-cel..:

Demel, Uta M ; Wirth, Matthias ; Yousefian, Schayan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890013/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Activated SUMOylation restricts MHC class I antigen present..:

Demel, Uta M ; Böger, Marlitt ; Yousefian, Schayan...
https://resolver.sub.uni-goettingen.de/purl?gro-2/136510. , 2022

Link: https://resolver.sub.uni..

15

A complex proinflammatory cascade mediates the activation o..:

Demel, Uta Margareta ; Lutz, Raphael ; Sujer, Stefanie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198917/. , 2022

Link: http://www.ncbi.nlm.nih...